Search

Search bills, members, committees and pages...

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)

16 federal lobbying filings, 2023 to 2026.

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) is a registrant on 16 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Clients

1 who it filed for, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20262$1.4M
20255$4.6M
20244$3.4M
20235$3.4M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues16
MMMMedicare/Medicaid16
PHAPharmacy16
TAXTaxation/Internal Revenue Code11
TARTariff (miscellaneous tariff bills)10
MANManufacturing5

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 2484Seniors’ Access to Critical Medications Act of 20257
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.5
H.R. 2120ROCR Value Based Program Act5
H.R. 2444Promoting Resilient Supply Chains Act of 20255
H.R. 3164Ensuring Community Access to Pharmacist Services Act5
H.R. 3514Improving Seniors’ Timely Access to Care Act of 20255
H.R. 3521Clinical Trial Modernization Act5
H.R. 879Medicare Patient Access and Practice Stabilization Act of 20255
S. 1816Improving Seniors’ Timely Access to Care Act of 20255
S. 257Promoting Resilient Supply Chains Act of 20255
H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act4
H.R. 2474Expanding Appalachia’s Broadband Access Act2
H.R. 2630Youth Suicide Prevention Research Act2
H.R. 3173Federal Reserve Financial Accountability and Transparency Act2
H.R. 3561FORCE Act2
H.R. 4011Community Paramedicine Act of 20252
H.R. 4473BIRD Health Act of 20252
H.R. 5376Impacts and Outcomes for Health Career Training Act2
S. 127Whole-Home Repairs Act of 20252
S. 1339Stop CCP Money Laundering Act of 20252
S. 3018A bill to permit visiting dignitaries and service members from Taiwan to display the flag of the Republic of…2
S. 3822Break Up Big Medicine Act2
S. 652Protecting Patients from Deceptive Drug Ads Act2

Lobbyists

Named on the filings.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2026 second_quarter$530KJul 20, 2026
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2026 first_quarter$860KApr 20, 2026
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2025 fourth_quarter$1.2MJan 19, 2026
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2025 third_quarter$530KOct 20, 2025
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2025 second_quarter$460KJul 17, 2025
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2025 first_quarter$1.2MApr 24, 2025
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2025 first_quarter$1.2MApr 21, 2025
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2024 fourth_quarter$560KJan 21, 2025
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2024 third_quarter$640KOct 17, 2024
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2024 second_quarter$650KJul 19, 2024
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2024 first_quarter$1.6MApr 17, 2024
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2023 fourth_quarter$720KJan 21, 2024
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2023 third_quarter$530KOct 20, 2023
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2023 first_quarter$1.2MAug 9, 2023
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2023 second_quarter$510KJul 20, 2023
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONSMCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)2023 first_quarter$440KApr 20, 2023